Therapies targeting TNF-α are now also recognized to be effective in multiple other chronic inflammatory diseases, including juvenile RA (JRA), Crohn’s disease, psoriasis, psoriatic arthritis, and ankylosing spondylitis [41]. The gene discussed is TNF; the disease is Crohn disease.